cyproterone acetate, ethinyl estradiol drug combination has been researched along with Thromboembolism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rowe, TC | 1 |
1 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Thromboembolism
Article | Year |
---|---|
First-use risks.
Topics: Androgen Antagonists; Canada; Consumer Product Safety; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |